Calidi Biotherapeutics -CW23CLDWWPreferred / convertible
13F holders, Q1 2024 (March 31)16holders
1famous investor
$0.05avg. 13F price*
At the end of Q1 2024, 16 institutions reported holding Calidi Biotherapeutics -CW23 (CLDWW) in their 13F filings. The largest holders were Polar Asset Management Partners Inc. ($119K), Finepoint Capital LP ($34K) and 683 Capital Management, LLC ($31K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Calidi Biotherapeutics -CW23
- CUSIP
- 320703119
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $832 |
| Exits | 3 | $3K |
Ownership 16 holders
| Polar Asset Management Partners Inc. | — | No change | 2,165,086 | $119K |
| Finepoint Capital LP | — | No change | 655,200 | $34K |
| 683 Capital Management, LLC | — | No change | 600,000 | $31K |
| Aristeia Capital, L.L.C. | — | No change | 494,400 | $27K |
| Nomura Holdings Inc. | — | No change | 467,818 | $24K |
| Shaolin Capital Management LLC | — | No change | 450,000 | $23K |
| Arena Investors LP | — | No change | 333,333 | $17K |
| Cowen and Company, LLC | — | Reduce -0.1% | 172,136 | $9K |
| EHP Funds Inc. | — | No change | 107,964 | $6K |
| Exos Asset Management LLC | — | — | 105,000 | $5K |
| Walleye Capital LLC | — | No change | 36,469 | $2K |
| Walleye Trading LLC | — | No change | 20,052 | $1K |
| Citadel Advisors | — | New | 15,873 | $825 |
| Clear Street LLC | — | No change | 1,746 | $91 |
| UBS Group AG | — | New | 133 | $7 |
| PNC Financial Services Group, Inc. | — | No change | 50 | $3 |
"% of holder's portfolio" is CLDWW's weight in each manager's 13F, not the share of Calidi Biotherapeutics -CW23 the manager owns.